• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤微环境与免疫细胞之间的相互作用调控肿瘤的进展和抑制。

The Give-and-Take Interaction Between the Tumor Microenvironment and Immune Cells Regulating Tumor Progression and Repression.

机构信息

Reprograming Tumor Activity and Associated Microenvironment (RYTME), Bordeaux Institute of Oncology (BRIC)-Unité Mixte de Recherche (UMR) 1312 Inserm, Pessac, France.

Institut Bergonié, Bordeaux, France.

出版信息

Front Immunol. 2022 Apr 13;13:850856. doi: 10.3389/fimmu.2022.850856. eCollection 2022.

DOI:10.3389/fimmu.2022.850856
PMID:35493456
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9043524/
Abstract

A fundamental concern of the majority of cancer scientists is related to the identification of mechanisms involved in the evolution of neoplastic cells at the cellular and molecular level and how these processes are able to control cancer cells appearance and death. In addition to the genome contribution, such mechanisms involve reciprocal interactions between tumor cells and stromal cells within the tumor microenvironment (TME). Indeed, tumor cells survival and growth rely on dynamic properties controlling pro and anti-tumorigenic processes. The anti-tumorigenic function of the TME is mainly regulated by immune cells such as dendritic cells, natural killer cells, cytotoxic T cells and macrophages and normal fibroblasts. The pro-tumorigenic function is also mediated by other immune cells such as myeloid-derived suppressor cells, M2-tumor-associated macrophages (TAMs) and regulatory T (Treg) cells, as well as carcinoma-associated fibroblasts (CAFs), adipocytes (CAA) and endothelial cells. Several of these cells can show both, pro- and antitumorigenic activity. Here we highlight the importance of the reciprocal interactions between tumor cells and stromal cells in the self-centered behavior of cancer cells and how these complex cellular interactions control tumor progression and repression.

摘要

大多数癌症科学家关注的一个基本问题是确定肿瘤细胞在细胞和分子水平上发生癌变的机制,以及这些过程如何能够控制癌细胞的出现和死亡。除了基因组的贡献外,这些机制还涉及肿瘤微环境(TME)中肿瘤细胞与基质细胞之间的相互作用。事实上,肿瘤细胞的存活和生长依赖于控制促癌和抗癌过程的动态特性。TME 的抗癌功能主要由免疫细胞如树突状细胞、自然杀伤细胞、细胞毒性 T 细胞和巨噬细胞以及正常成纤维细胞调节。促癌功能也由其他免疫细胞如髓源性抑制细胞、M2 肿瘤相关巨噬细胞(TAMs)和调节性 T(Treg)细胞以及癌相关成纤维细胞(CAFs)、脂肪细胞(CAA)和内皮细胞介导。其中一些细胞可以表现出促癌和抗癌活性。在这里,我们强调了肿瘤细胞与基质细胞之间相互作用在癌细胞自我中心行为中的重要性,以及这些复杂的细胞相互作用如何控制肿瘤的进展和抑制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ea5/9043524/b90d16870388/fimmu-13-850856-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ea5/9043524/5f10a5913239/fimmu-13-850856-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ea5/9043524/02d208ae254e/fimmu-13-850856-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ea5/9043524/992b00311413/fimmu-13-850856-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ea5/9043524/273b3f1a9917/fimmu-13-850856-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ea5/9043524/d3d28f7a9bed/fimmu-13-850856-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ea5/9043524/b90d16870388/fimmu-13-850856-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ea5/9043524/5f10a5913239/fimmu-13-850856-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ea5/9043524/02d208ae254e/fimmu-13-850856-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ea5/9043524/992b00311413/fimmu-13-850856-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ea5/9043524/273b3f1a9917/fimmu-13-850856-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ea5/9043524/d3d28f7a9bed/fimmu-13-850856-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ea5/9043524/b90d16870388/fimmu-13-850856-g006.jpg

相似文献

1
The Give-and-Take Interaction Between the Tumor Microenvironment and Immune Cells Regulating Tumor Progression and Repression.肿瘤微环境与免疫细胞之间的相互作用调控肿瘤的进展和抑制。
Front Immunol. 2022 Apr 13;13:850856. doi: 10.3389/fimmu.2022.850856. eCollection 2022.
2
Carcinoma-Associated Mesenchymal Stem/Stromal Cells: Architects of the Pro-tumorigenic Tumor Microenvironment.癌相关间充质干细胞/基质细胞:致瘤性肿瘤微环境的建筑师。
Stem Cells. 2022 Aug 25;40(8):705-715. doi: 10.1093/stmcls/sxac036.
3
Inflammatory Components of the Thyroid Cancer Microenvironment: An Avenue for Identification of Novel Biomarkers.甲状腺癌微环境中的炎症成分:鉴定新型生物标志物的途径。
Adv Exp Med Biol. 2021;1350:1-31. doi: 10.1007/978-3-030-83282-7_1.
4
Cancer-associated fibroblasts (CAFs) and tumor-associated macrophages (TAMs); where do they stand in tumorigenesis and how they can change the face of cancer therapy?癌相关成纤维细胞(CAFs)和肿瘤相关巨噬细胞(TAMs);它们在肿瘤发生中处于什么地位,以及它们如何改变癌症治疗的面貌?
Eur J Pharmacol. 2022 Aug 5;928:175087. doi: 10.1016/j.ejphar.2022.175087. Epub 2022 Jun 6.
5
CAFs vs. TECs: when blood feuds fuel cancer progression, dissemination and therapeutic resistance.成纤维细胞与上皮细胞:当血液世仇助长癌症进展、扩散和治疗抵抗时。
Cell Oncol (Dordr). 2024 Aug;47(4):1091-1112. doi: 10.1007/s13402-024-00931-z. Epub 2024 Mar 7.
6
Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.癌症相关成纤维细胞靶向策略增强基于树突状细胞疫苗的抗肿瘤免疫反应。
Cancer Sci. 2015 Feb;106(2):134-42. doi: 10.1111/cas.12584. Epub 2015 Jan 16.
7
Interaction of tumor‑associated macrophages with stromal and immune components in solid tumors: Research progress (Review).肿瘤相关巨噬细胞与实体瘤中基质和免疫成分的相互作用:研究进展(综述)。
Int J Oncol. 2023 Feb;62(2). doi: 10.3892/ijo.2023.5480. Epub 2023 Jan 20.
8
Cancer associated fibroblasts sculpt tumour microenvironment by recruiting monocytes and inducing immunosuppressive PD-1 TAMs.癌症相关成纤维细胞通过招募单核细胞和诱导免疫抑制 PD-1 TAMs 来塑造肿瘤微环境。
Sci Rep. 2019 Feb 28;9(1):3172. doi: 10.1038/s41598-019-39553-z.
9
Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.肿瘤微环境中癌症相关成纤维细胞与免疫细胞的串扰:新发现与未来展望。
Mol Cancer. 2021 Oct 11;20(1):131. doi: 10.1186/s12943-021-01428-1.
10
Cancer-associated fibroblasts promote an immunosuppressive microenvironment through the induction and accumulation of protumoral macrophages.癌症相关成纤维细胞通过诱导和积累促肿瘤巨噬细胞来促进免疫抑制微环境。
Oncotarget. 2017 Jan 31;8(5):8633-8647. doi: 10.18632/oncotarget.14374.

引用本文的文献

1
RESEARCH CHALLENGES IN STAGE III AND IV RAS-ASSOCIATED CANCERS: A Narrative Review of the Complexities and Functions of the Family of Genes and Ras Proteins in Housekeeping and Tumorigenesis.III期和IV期RAS相关癌症的研究挑战:关于管家基因和肿瘤发生过程中基因家族及Ras蛋白的复杂性与功能的叙述性综述
Biology (Basel). 2025 Jul 25;14(8):936. doi: 10.3390/biology14080936.
2
In-depth insight into tumor-infiltrating stromal cells linked to tertiary lymphoid structures and their prospective function in cancer immunotherapy.深入了解与三级淋巴结构相关的肿瘤浸润性基质细胞及其在癌症免疫治疗中的潜在功能。
Exp Hematol Oncol. 2025 Aug 10;14(1):105. doi: 10.1186/s40164-025-00695-8.
3

本文引用的文献

1
The proprotein convertase furin in cancer: more than an oncogene.蛋白原转化酶 furin 在癌症中的作用:不止是一种癌基因。
Oncogene. 2022 Feb;41(9):1252-1262. doi: 10.1038/s41388-021-02175-9. Epub 2022 Jan 7.
2
Furin Prodomain ppFurin Enhances Ca Entry Through Orai and TRPC6 Channels' Activation in Breast Cancer Cells.弗林蛋白酶前结构域pp弗林蛋白酶通过激活乳腺癌细胞中的Orai和TRPC6通道增强钙离子内流。
Cancers (Basel). 2021 Apr 1;13(7):1670. doi: 10.3390/cancers13071670.
3
Cancer-associated fibroblasts: overview, progress, challenges, and directions.
Determination of high-grade serous ovarian cancer stem cell-based subtypes and prognostic model and identification of highly expressed VSIG4 and STAB1 in macrophages.
基于高级别浆液性卵巢癌干细胞的亚型及预后模型的确定以及巨噬细胞中高表达的VSIG4和STAB1的鉴定。
J Ovarian Res. 2025 Jul 23;18(1):159. doi: 10.1186/s13048-025-01747-7.
4
A high proportion of CD38 (high) CD16 (low) NK cells in colorectal cancer can interrupt immune surveillance and favor tumor growth.结直肠癌中高比例的CD38(高表达)CD16(低表达)自然杀伤细胞会破坏免疫监视并促进肿瘤生长。
Cancer Immunol Immunother. 2025 Jul 12;74(8):263. doi: 10.1007/s00262-025-04044-w.
5
The prognostic significance of desmoplastic reaction, tumor budding and tumor-infiltrating lymphocytes in esophageal squamous cell carcinomas.促纤维增生性反应、肿瘤芽生及肿瘤浸润淋巴细胞在食管鳞状细胞癌中的预后意义
BMC Gastroenterol. 2025 Jul 1;25(1):476. doi: 10.1186/s12876-025-03984-y.
6
Evaluation of tumor budding, desmoplastic reaction, and lymphocytic infiltration in predicting survival for pancreatic ductal adenocarcinoma.评估肿瘤芽生、促纤维增生性反应和淋巴细胞浸润对预测胰腺导管腺癌生存率的作用。
World J Gastrointest Oncol. 2025 Jun 15;17(6):107021. doi: 10.4251/wjgo.v17.i6.107021.
7
Unraveling the complex role of tumor-associated neutrophils within solid tumors.解析实体瘤内肿瘤相关中性粒细胞的复杂作用。
Cancer Immunol Immunother. 2025 May 19;74(7):210. doi: 10.1007/s00262-025-04049-5.
8
Genomic and micro-environmental insights into drug resistance in colorectal cancer liver metastases.结直肠癌肝转移耐药性的基因组和微环境见解
Discov Oncol. 2025 Feb 26;16(1):241. doi: 10.1007/s12672-025-01976-8.
9
Innovative landscapes in intraperitoneal therapy of ovarian cancer.卵巢癌腹腔内治疗的创新前景。
Drug Deliv Transl Res. 2025 Jun;15(6):1877-1906. doi: 10.1007/s13346-024-01765-w. Epub 2025 Jan 31.
10
The Role of Immunotherapy in Lung Cancer Treatment: Current Strategies, Future Directions, and Insights into Metastasis and Immune Microenvironment.免疫疗法在肺癌治疗中的作用:当前策略、未来方向以及对转移和免疫微环境的见解
Curr Gene Ther. 2025 Jan 6. doi: 10.2174/0115665232340926241105064739.
癌症相关成纤维细胞:概述、进展、挑战和方向。
Cancer Gene Ther. 2021 Sep;28(9):984-999. doi: 10.1038/s41417-021-00318-4. Epub 2021 Mar 12.
4
Metabolic crosstalk in the tumor microenvironment regulates antitumor immunosuppression and immunotherapy resisitance.肿瘤微环境中的代谢串扰调节抗肿瘤免疫抑制和免疫治疗抵抗。
Cell Mol Life Sci. 2021 Jan;78(1):173-193. doi: 10.1007/s00018-020-03581-0. Epub 2020 Jul 11.
5
Innate immune cells in cirrhosis.肝硬化中的固有免疫细胞。
J Hepatol. 2020 Jul;73(1):186-201. doi: 10.1016/j.jhep.2020.03.027. Epub 2020 Mar 30.
6
Proteomic Analysis of Exosomes from Adipose-Derived Mesenchymal Stem Cells: A Novel Therapeutic Strategy for Tissue Injury.脂肪间充质干细胞来源外泌体的蛋白质组学分析:一种组织损伤的新型治疗策略。
Biomed Res Int. 2020 Mar 3;2020:6094562. doi: 10.1155/2020/6094562. eCollection 2020.
7
Proprotein convertases: Key players in inflammation-related malignancies and metastasis.蛋白转化酶:炎症相关恶性肿瘤和转移的关键因素。
Cancer Lett. 2020 Mar 31;473:50-61. doi: 10.1016/j.canlet.2019.12.027. Epub 2019 Dec 30.
8
Tumor angiogenesis: causes, consequences, challenges and opportunities.肿瘤血管生成:原因、后果、挑战与机遇。
Cell Mol Life Sci. 2020 May;77(9):1745-1770. doi: 10.1007/s00018-019-03351-7. Epub 2019 Nov 6.
9
Cancer-associated adipocytes: key players in breast cancer progression.癌相关脂肪细胞:乳腺癌进展中的关键角色。
J Hematol Oncol. 2019 Sep 10;12(1):95. doi: 10.1186/s13045-019-0778-6.
10
Inactivation of Proprotein Convertases in T Cells Inhibits PD-1 Expression and Creates a Favorable Immune Microenvironment in Colorectal Cancer.T 细胞中蛋白原转化酶的失活抑制 PD-1 的表达,并在结直肠癌中创造有利的免疫微环境。
Cancer Res. 2019 Oct 1;79(19):5008-5021. doi: 10.1158/0008-5472.CAN-19-0086. Epub 2019 Jul 29.